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Introduction: Few cases of neuromyelitis optica have been reported in Africa. This is the first case report of
neuromyelitis optica in Uganda. It highlights the need to have a high index of suspicion to promptly identify and
appropriately treat these patients.
Case presentation: We present the case of a 24-year-old woman of Bantu origin who presented initially with
bilateral loss of vision and weakness of the lower limbs in 2010 that resolved completely after a few days. Eight
months later, she presented with bilateral lower limb weakness and urinary incontinence that improved completely
following steroid use. This was followed four months later with an episode of quadriparesis that was treated with
steroids and azathioprine with some improvement currently using a walking aide.
Conclusions: The patient described here represents a phenotypic expression of a recurrent (multiphasic), steroid-
sensitive, inflammatory demyelinating disorder of the central nervous system occurring in a black Ugandan woman.
This case highlights the occurrence of Devic’s disease within our setting and the need to properly diagnose this
condition even in a resource-limited setting to prevent disability.
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Neuromyelitis optica (Devic’s syndrome) is defined as a
devastating myelitis with the following: an acute unilateral
or bilateral optic neuropathy, no clinical involvement be-
yond the spinal cord or optic nerves, and a monophasic
or, rarely, a multiphasic illness [1-3]. The discovery of
neuromyelitis optica (NMO) immunoglobulin G (IgG),
directed against aquaporin-4 (AQP4), has dramatically
changed the clinical definition of NMO and is important
in the diagnostic criteria of this disease [4,5]. However, in
resource-limited centers this may be a limitation in meet-
ing the formal diagnostic criteria pathway due to labora-
tory diagnostic setbacks.
No cases have been documented in Uganda and this is
the first case reported in Uganda or surrounding equato-
rial regions in Sub-Saharan Africa. The low anticipation of
such diseases in our setting, coupled with diagnostic chal-
lenges, often leads to misdiagnosis and worse outcomes in
patients that could have benefited from readily available* Correspondence: kaddumark@yahoo.co.uk
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distribution, and reproduction in any mediumtreatment. We believe the insights offered here may be
useful to many other resource-limited settings.
Case presentation
A 24-year-old African woman of Bantu origin presented
to us in 2010 with sudden bilateral loss of vision and
progressive weakness in both her lower limbs for one
day. She had been previously well with no known
chronic medical conditions, like hypertension or diabetes
mellitus, and had no preceding vaccinations or viral in-
fections noted. She has lived all her life in Uganda. Her
brain computed tomography (CT) scan was normal and
her blood test results were negative for polycythemia,
thrombocytosis, and diabetes mellitus. Her systemic clin-
ical examination, including the neurological assessment
at the time of her initial medical presentation, was nor-
mal. She was treated as if she were a patient suffering a
transient ischemic attack, with low-dose aspirin (ASA),
which she later decided to stop over the course of time.
Eight months later, she presented to us with inability
to walk and urinary incontinence for three days. This
was preceded by parethesias in the lower limbs followed
by unsteady gait and subsequently, an inability to useentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Figure 1 Magnetic resonance imaging studies. Sagittal T2-weighted
magnetic resonance imaging showed hyperintense ill-defined lesions
from T4 – T8.
Kaddumukasa et al. Journal of Medical Case Reports 2013, 7:177 Page 2 of 3
http://www.jmedicalcasereports.com/content/7/1/177both her lower limbs and urinary incontinence. She
reported no history of recent vaccinations, ingestion of
tinned meats or beef and no recent sore throat. Her vi-
sion this time was normal with no complaints of double
vision or visual field defects. Her upper limbs were nor-
mal. She was nulliparus and reported normal menses.
She reported no history of hypertension or diabetes, and
was not receiving any regular medications.
Clinically, she had muscle power grade 2 on the
Medical Research Council (MRC) scale bilaterally, with
spasticity and brisk reflexes of the knees and ankles
bilaterally, with bilateral upgoing plantars. She had a
symmetrical sensory deficit below T10 to fine touch and
pressure. Her vision was normal with no visual field de-
fects or double images and no optic atrophy or optic
neuritis was detected on fundoscopy. She had urinary
retention and a urinary catheter was placed in situ. Her
series of blood test requests returned negative results
for human immunodeficiency virus (HIV)1/2 testing
and the treponema pallidum hemagglutination assay
(TPHA)/Venereal Disease Research Laboratory test
(VDRL) test for syphilis. Her peripheral blood film
report revealed no malarial parasites or other hemo-
parasites. The full blood counts showed the following:
the white blood cell count (WBC) was 10.2 × 103/L, ab-
solute neutrophils 7.1 × 103/L, lymphocytes 1.3 × 103,
hemoglobin 11.6g/dL and platelets 252 × 103. She had
elevated acute-phase reactants with an erythrocyte sedi-
mentation rate (ESR) of 25mm/hr (Westergren method)
and C-reactive protein (CRP) of 17mg/L but her antinu-
clear antibodies test was negative. A lumbar puncture
performed showed the cerebrospinal fluid (CSF) was
clear and colorless, with a normal blood glucose level.
However, the CSF protein content was elevated at
60mg/dL, while the WBC count in the CSF was less
than 5 cells/uL. Indian ink staining on her CSF for
Cryptococcus was negative and the Gram stain revealed
no organisms. The Ziehl-Neelsen stain for tuberculosis
revealed no acid-fast bacilli. The VDRL on the CSF was
nonreactive and cytology revealed no malignant cells.
She had no clinical evidence of sarcoidosis, vasculitis,
systemic lupus erythematosus (SLE) or Sjogren’s syn-
drome. A brain and spinal magnetic resonance imaging
(MRI) scan was requested for further evaluation.
Her MRI of the cervicothoracic spine revealed large
multiple ill-defined hyperintense lesions involving the
cervical and thoracic spinal cord up to the T4 to T8
vertebral levels on T2-weighted images (Figure 1). These
appeared hypointense on T1-weighted images, probably
representing myelitis or demyelination. No cord com-
pressive lesions were found on her spinal MRI and her
brain MRI was normal. A diagnosis of neuromyelitis
optica was made based on the diagnostic criteria exclud-
ing the antibody assays [6].She was started on pulse methyprednisolone 1g for
five days and had complete resolution of her symptoms.
She was discharged from hospital on tapering oral ste-
roids but the patient stopped the low-dose oral steroids
after two months of treatment. Due to lack of prior ex-
perience of the disease, she was not started on long-term
steroid-sparing immunosuppressants like azathioprine or
mycophenolate mofetil, which are readily available within
the country though costly.
In February 2011, that is four months later, she
returned to our care with sudden loss of sensation and
numbness in the upper limbs and weakness in the lower
limbs. Her power grading using the MRC scale was four
minus in the upper limbs and two in the lower limbs re-
spectively. We were unable to repeat the MRI scan due
to limited resources and therefore unable to evaluate the
presence and extent of any new lesions. The patient then
received pulse therapy of methyprednisolone 1g once a
day for five days, there was improvement in her lower
limbs, and her power increased to four minus after
about two weeks’ admission. She was able to walk with
support and was started on daily tapered prednisolone
and azathioprine starting at 2mg/kg/day, divided into
two daily doses. She was not tested for the thiopurine S-
methyltransferase (TPMT) mutation. Individuals who
have this mutation can develop significant bone marrow
toxicity with azathioprine; however, she gets a routine
monthly blood check especially for the WBC counts.
She was recommended to physiotherapy for muscle-
strengthening exercises and bladder training. She has
remained fairly stable, able to walk with the aid of a walk-
ing stick and is still under our follow-up care. She is
currently maintained on azathioprine 100mg daily and the
oral steroids have been gradually tapered off. We are
continuing to monitor her WBC counts every month for
leucopenia and liver function associated with azathioprine
Kaddumukasa et al. Journal of Medical Case Reports 2013, 7:177 Page 3 of 3
http://www.jmedicalcasereports.com/content/7/1/177toxicity. She has remained stable and has not suffered any
more relapses since then.
We are unable to perform the AQP4 antibodies test in
our setting.
Discussion
This case shows the complexities of diagnosing neuromy-
elitis optica in a resource-limited setting, especially in geo-
graphic areas initially thought not to have a burden of this
disease. It is reported to be rare in our setting, though
cases have been documented elsewhere [7-9]. And hence
there is a need to adequately prepare for similar treatment
challenges.
Therefore, a high index of suspicion is required to make
this diagnosis early and illustrate the need for early and
prompt diagnosis to delay unfavorable outcomes [1,3].
Meeting the 2006 revised diagnostic criteria of NMO [6]
in our setting may still be difficult, especially with the
serological assays. Clinicians need to rely on the other
criterion and clinical judgments and initiate treatments so
as to delay the consequences of the disease.
Our case highlights the fact that lack of the laboratory
diagnostic criteria, such as detection of oligiclonal bands and
of AQP4 antibodies, does not preclude the diagnosis and
correct treatment approach in cases like the one described.
Conclusions
Our case report is further strong evidence that neuromy-
elitis optica occurs in Uganda and Africa as a whole and
requires a high index of suspicion and improvement in
health-care provision to NMO patients in our setting.
Proper training of medical personnel and students to
promptly make a diagnosis and refer such cases for spe-
cialized care is required. Our patient had three episodes
over a span of two years and suffered delays in instituting
treatment due to lack of awareness as well as in planning
long-term care for the patient. The availability of easier
and faster assays would help in the decision-making of
patient care. The limitations of determining oligoclonal
bands and NMO-IgG antibodies in a resource-limited
setting should not delay the process of making a diagnosis
of NMO in tropical Africa.
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